Edition:
United Kingdom

Allison Martell

Unpaid bills, empty homes: Families of Iran crash victims put lives back together

08 Feb 2020

TORONTO Grief-stricken relatives of passengers killed aboard an airliner shot down by Iran over Tehran last month are grappling in Canada with the daily challenges of long-distance funeral arrangements, empty homes, cars left in driveways and unpaid bills. | Video

Canadian lawyers file lawsuit against Iran over victims of downed Ukrainian plane

07 Feb 2020

TORONTO Canadian lawyers, who previously successfully sued Iran, are seeking class action status in a lawsuit on behalf of victims aboard a Ukrainian plane shot down over Tehran last month, looking for at least C$1.5 billion ($1.1 billion) in compensation.

Canadian drug distributors say no to Trump import plan

20 Dec 2019

TORONTO Many of Canada's drug suppliers cannot, or will not, agree to ship cheaper prescription medicines into the United States, a new challenge to the Trump administration's push to reduce drug prices, companies and industry officials told Reuters.

Canadian drug distributors say no to Trump import plan

20 Dec 2019

TORONTO, Dec 20 Many of Canada's drug suppliers cannot, or will not, agree to ship cheaper prescription medicines into the United States, a new challenge to the Trump administration's push to reduce drug prices, companies and industry officials told Reuters.

Ontario focused on rare disease drugs ahead of national drug plan talks

02 Dec 2019

TORONTO The Canadian province of Ontario will push for the federal government to tackle the high cost of treatments for rare diseases as negotiations over a new national prescription drug program are set to kick off, the province's health minister told Reuters on Monday.

J&J blockbuster loses ground to biosimilars despite Quebec court ruling

13 Nov 2019

TORONTO/MONTREAL Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.

J&J's Remicade losing ground in Quebec health plan despite court victory

13 Nov 2019

TORONTO/MONTREAL, Nov 13 Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.

Canadian ambassador says drug imports would not lower U.S. prices

01 Nov 2019

OTTAWA Canada does not have a large enough supply of prescription drugs to meet U.S. demand, and importing medicines from Canada would not significantly lower U.S. prices, Ottawa's acting ambassador told U.S. officials in recent meetings, according to a statement published on Friday.

Deaths, bad outcomes elude scrutiny at Canada's indigenous clinics

24 Oct 2019

TORONTO Ina Matawapit was barely conscious - intoxicated and suffering from a blow to the head - when police drove her to the North Caribou Lake clinic in Ontario, Canada, one summer evening in 2012.

Canadian election clears path for universal drug plan

23 Oct 2019

TORONTO Canada's Liberal government is more likely to pass a universal prescription drug plan after losing its majority in Monday's election, setting the stage for what would be the biggest shakeup of the country's public healthcare system since it was created in the 1960s.

World News